Almarys is listed on the Official Market of the Stock Exchange of Mauritius. The company holds 13,300 arpents of strategically located agricultural land and a 25.38% equity stake in Société Helicophanta. Through investment in Almarys, shareholders access a strategic minority stake in a world-class biotech company offering both recurring cash flows and medium-term growth potential.
Almarys offers a blend of asset-backed security and innovative growth opportunities to its shareholders.
Almarys’ Annual Report 2025 reflects its commitment to sustainable value creation and transparent reporting.
Covering the financial year ended 30 June 2025, it outlines our approach to managing risks, opportunities, and outcomes across our business.
Strong asset base
Shareholders will own a company with significant land holdings.
Stable recurring revenue
Consistent cash flows from Société Helicophanta and the rental of land.
Long-term growth potential
Appreciation potential of land holdings; strategic entry into the emerging biotechnology sector.
Almarys is listed on the Official Market of the Stock Exchange of Mauritius. The Company holds 13,300 arpents of agricultural land and a 25.38% equity stake in Société Helicophanta.
Copyright © 2026 Almarys | Concept and Development by Diizz
